Closure of trading window for the period ending on 30th September, 2026.

Date: 29.09.2026 BSE Limited P. J. Towers, Dalal Street, Mumbai – 400001. Dear Sir / Madam, Sub: Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 Unit: Oxygenta Pharmaceutical Limited (Scrip Code: 524636) With reference to the subject cited and pursuant to the Company’s Code of Conduct for Prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window for dealing in the securities of the Company will remain closed from 01.10.2026 till 48 hours after the declaration of Financial Results for the Quarter and Half Year ending on 30.09.2026 for all designated persons, their immediate relatives and all connected persons covered under the Company’s Code of Conduct. The Board Meeting will be scheduled, inter-alia, to consider and approve the Financial Results for the quarter and half year ending 30.09.2026. Accordingly, an intimation regarding the notice of Board Meeting shall be sent separately to the Stock Exchange. Further, the designated persons have been intimated not to trade in the securities of the Company during the above said period of closure of trading window. This is for the information and records of the Exchange, please. Thanking you. Yours faithfully, For Oxygenta Pharmaceutical Limited Kumkum Bajaj Company Secretary & Compliance Officer M No. A76548